164 related articles for article (PubMed ID: 7113955)
21. Prospective evaluation of resting energy expenditure, nutritional status, pulmonary function, and genotype in children with cystic fibrosis.
Zemel BS; Kawchak DA; Cnaan A; Zhao H; Scanlin TF; Stallings VA
Pediatr Res; 1996 Oct; 40(4):578-86. PubMed ID: 8888286
[TBL] [Abstract][Full Text] [Related]
22. Endogenous 3-methylhistidine excretion in healthy women and men with reference to muscle protein metabolism.
Neuhäuser M; Bässler KH
Z Ernahrungswiss; 1984 Sep; 23(3):171-80. PubMed ID: 6506809
[TBL] [Abstract][Full Text] [Related]
23. Nitrogen deposition in malnourished children with cystic fibrosis.
Baur LA; Waters DL; Allen BJ; Blagojevic N; Gaskin KJ
Am J Clin Nutr; 1991 Feb; 53(2):503-11. PubMed ID: 1989418
[TBL] [Abstract][Full Text] [Related]
24. Adolescent development and energy expenditure in females with cystic fibrosis.
Stallings VA; Tomezsko JL; Schall JI; Mascarenhas MR; Stettler N; Scanlin TF; Zemel BS
Clin Nutr; 2005 Oct; 24(5):737-45. PubMed ID: 16182037
[TBL] [Abstract][Full Text] [Related]
25. Studies on 3-methylhistidine metabolism in children with protein-energy malnutrition.
Nagabhushan VS; Narasinga Rao BS
Am J Clin Nutr; 1978 Aug; 31(8):1322-7. PubMed ID: 98037
[TBL] [Abstract][Full Text] [Related]
26. Total body potassium in cystic fibrosis.
Shepherd RW; Holt TL; Greer R; Cleghorn GJ; Thomas BJ
J Pediatr Gastroenterol Nutr; 1989 Aug; 9(2):200-5. PubMed ID: 2809940
[TBL] [Abstract][Full Text] [Related]
27. Nutritional status of children with clinical conditions.
Murphy AJ; Hill RJ; Buntain H; White M; Brookes D; Davies PSW
Clin Nutr; 2017 Jun; 36(3):788-792. PubMed ID: 27289162
[TBL] [Abstract][Full Text] [Related]
28. Urinary excretion of 3-methylhistidine: an assessment of muscle protein catabolism in adult normal subjects and during malnutrition, sepsis, and skeletal trauma.
Long CL; Birkhahn RH; Geiger JW; Betts JE; Schiller WR; Blakemore WS
Metabolism; 1981 Aug; 30(8):765-76. PubMed ID: 6790901
[TBL] [Abstract][Full Text] [Related]
29. [Absence of effect of propranolol on urinary excretion of 3-methylhistidine in hyperthyroidism].
Beylot M; Riou JP; Sautot G; Mornex R
Presse Med; 1984 Sep 1-8; 13(30):1829-31. PubMed ID: 6236442
[TBL] [Abstract][Full Text] [Related]
30. Comparison of human myofibrillar protein catabolic rate derived from 3-methylhistidine excretion with synthetic rate from muscle biopsies during L-[alpha-15N]lysine infusion.
McKeran RO; Halliday D; Purkiss P
Clin Sci Mol Med; 1978 May; 54(5):471-5. PubMed ID: 750147
[TBL] [Abstract][Full Text] [Related]
31. Increased contribution by myofibrillar protein to whole-body protein breakdown according to severity of surgical stress.
Tashiro T; Yamamori H; Takagi K; Morishima Y; Nakajima N
Nutrition; 1996 Oct; 12(10):685-9. PubMed ID: 8936491
[TBL] [Abstract][Full Text] [Related]
32. [Urinary excretion of 3-methylhistidine. Value and application to the study of protein catabolism].
Richard JL; Rodier M; Bringer J; Cavalie G; Claustres M; Bellet H; Mirouze J
Presse Med; 1985 Jan; 14(2):91-4. PubMed ID: 3156332
[TBL] [Abstract][Full Text] [Related]
33. Increased whole body hydroxyproline production as assessed by a new stable isotope technique is associated with hip and spine bone mineral loss in cystic fibrosis.
Engelen MP; Com G; Deutz NE
Clin Nutr; 2014 Dec; 33(6):1117-21. PubMed ID: 24423745
[TBL] [Abstract][Full Text] [Related]
34. Muscle protein degradation in severely malnourished patients with chronic obstructive pulmonary disease subject to short-term total parenteral nutrition.
Aguilaniu B; Goldstein-Shapses S; Pajon A; Levy P; Sarrot F; Leverve X; Page E; Askanazi J
JPEN J Parenter Enteral Nutr; 1992; 16(3):248-54. PubMed ID: 1501355
[TBL] [Abstract][Full Text] [Related]
35. Use of body mass index percentile to identify fat-free mass depletion in children with cystic fibrosis.
Engelen MP; Schroder R; Van der Hoorn K; Deutz NE; Com G
Clin Nutr; 2012 Dec; 31(6):927-33. PubMed ID: 22607714
[TBL] [Abstract][Full Text] [Related]
36. 3-methylhistidine excretion in myotonic dystrophy.
Griggs RC; Moxley RT; Forbes GB
Neurology; 1980 Dec; 30(12):1262-7. PubMed ID: 7192806
[TBL] [Abstract][Full Text] [Related]
37. Measurements of myofibrillar protein breakdown in newborn human infants.
Burgoyne JL; Ballard FJ; Tomas FM; Dobozy A; MacLennan AH; Fitzgerald A; Dahlenburg GW
Clin Sci (Lond); 1982 Nov; 63(5):421-7. PubMed ID: 7116782
[TBL] [Abstract][Full Text] [Related]
38. Increased myofibrillar protein catabolism in Duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
McKeran RO; Halliday D; Purkiss P
J Neurol Neurosurg Psychiatry; 1977 Oct; 40(10):979-81. PubMed ID: 591977
[TBL] [Abstract][Full Text] [Related]
39. Nutritional rehabilitation increases resting energy expenditure without affecting protein turnover in patients with cystic fibrosis.
Vaisman N; Clarke R; Pencharz PB
J Pediatr Gastroenterol Nutr; 1991 Nov; 13(4):383-90. PubMed ID: 1779312
[TBL] [Abstract][Full Text] [Related]
40. Nutritional rehabilitation in cystic fibrosis: controlled studies of effects on nutritional growth retardation, body protein turnover, and course of pulmonary disease.
Shepherd RW; Holt TL; Thomas BJ; Kay L; Isles A; Francis PJ; Ward LC
J Pediatr; 1986 Nov; 109(5):788-94. PubMed ID: 3095520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
